Parkinson's disease (PD) is a neurodegenerative disorder that primarily affects middle-aged and elderly individuals, ranking second only to Alzheimer's disease. Currently, traditional medications have limited effectiveness in treating PD. Replacing or compensating for the damaged dopaminergic neurons with healthy ones through brain implantation may offer potential treatment or even cure for Parkinson's disease.

Diabetes mellitus (DM) is a metabolic disorder characterized by varying degrees of insulin deficiency or pancreatic dysfunction. Islet cell replacement therapy has the potential to become the most promising method to "end" insulin injections.

Leveraging innovative iPSC technology, Nuwacell overcomes limitations in cell quantity and reduces immunogenicity, offering high-purity, batch-consistent, and quality-stable “off-the-shelf” iPSC-derived iDAP and islet cell products.